Unilever's partnership with Algenuity upholds algae as an opportunity for the food industry

August 03, 2020
Emerging Ecosystems in Agrifood and Health More...
by Laura Krishfield
Very important

The economic viability of algae production is questionable for most products due to high production costs. Nevertheless, algae is suddenly attracting interest as a protein ingredient from major food companies – first with Nestlé and Corbion and now with Unilever's new partnership with Algenuity. The key differentiating factor for both of these algae developers is the use of scalable photobioreactor technology rather than open-pond systems. Above all, Algenuity claims differentiation in selective trait development of its strain to improve its algae powder's taste, smell, and nutritional content. Clients, when it comes to algae, only engage with developers that can succeed in producing high-value products worth the cost of production.

For the original news article, click here .

Further Reading

Plantible Foods

Company Snapshot | July 19, 2019

The company was founded by Tony Martens and Maurits van de Ven. So far, the company has raised about $500,000 from a seed round in 2018. Among its investors, we highlight Unshackled Ventures. The company makes lemna protein using a controlled indoor cultivation system and cold‑press extraction ... To read more, click here.

Menon Renewable Products

Company Snapshot | June 24, 2019

The company was founded by Suresh Menon, Ph.D.; Menon Renewable Products is a wholly owned subsidiary of Menon International. The company makes a feed ingredient (branded MrFeed) using a proprietary fermentation process called CelTherm. The CelTherm process converts cellulosic feedstock to a ... Not part of subscription

Zivo Bioscience

Company Snapshot | April 07, 2020

Zivo Bioscience was acquired by Howard Baer in 2003. To date, the company has raised approximately $110.68 million in total funding. The company produces algal biomass and bioactive compounds to be used as ingredients in food, supplements, and possibly medicine; the company's proprietary algal ... To read more, click here.